Neurogastrx is a private biopharmaceutical company focused on discovering and developing transformative therapies for gastrointestinal disorders affecting the enteric nervous system.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/04/18 | $45,000,000 | Series A |
5AM Ventures OrbiMed Advisors VenBio | undisclosed |
